In the United States, obesity-related ischemic heart disease (IHD) mortality is increasing, with the highest rates ...

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.

For all men, the rate jumped from 2.1 deaths per 100,000 people in 1999 to 7.2 in 2020 – a 243% increase. For men ages 55 to ...

Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the ...

The field of cardiovascular research has traditionally focused on the left heart's function, particularly in the context of left heart diseases (LHD), leading to significant advancements in ...

Scientists at deCODE genetics have published a study in Nature Communications that sheds light on how body mass index (BMI) ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...

Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...